Mutares Shuffles Portfolio and Trims Bond Ahead of 2026 Refinancing

Mutares cut its Nordic bond to about EUR 222 million, acquired Synthomer a.s. and Steinmüller Engineering, and exited Prénatal and Cimos.

Mutares has spent the closing weeks of the year reshaping both sides of its balance sheet, pairing a partial bond buyback with a burst of acquisition and divestment activity. The Munich-based holding company is positioning itself for a refinancing scheduled for the second half of the fourth quarter of 2026, while simultaneously reworking the mix of businesses it owns.

Bond Buyback Reduces Outstanding Volume

On Thursday, Mutares disclosed the outcome of its partial repurchase offer for its variable-rate Nordic bond due 2023/2027. The company accepted tendered notes with a combined nominal value of EUR 10.4 million in full, cutting the nominal amount held by investors to roughly EUR 222 million. Refinancing of the remaining obligations is planned for the latter half of Q4 2026.

The move gives management greater planning certainty before negotiations over a full replacement of the bond get under way, and it marks another step in tidying up the liability side of the balance sheet.

Two Acquisitions Bolster Industrial Core

On the buying side, Mutares completed the carve-out acquisition of Synthomer a.s. on Wednesday. The business generated revenue of about EUR 110 million in 2025 and employs roughly 300 people, and it will serve as a platform within the Chemicals & Materials segment.

A day earlier, on Tuesday, the company signed an agreement to acquire Steinmüller Engineering GmbH from IHI Corporation. The engineering firm posted total output of nearly EUR 100 million in its most recent financial year. Completion of that deal is subject to customary conditions and is expected in the fourth quarter of 2026. Together, the two transactions extend Mutares' industrial footprint and give it access to established engineering expertise that can be folded into existing structures.

Retail and Automotive Exits Continue

Divestments have moved in parallel. Mutares sold Dutch portfolio company Prénatal to its CEO, Jochem van Bueren, on 23 September — a step consistent with its stated plan to scale back exposure to retail. Cimos d.d. was handed over roughly two weeks ago to its own management team alongside investor Vero Automotive 111 d.o.o.; the shares have since slipped 4.5%.

The pattern reflects a deliberate approach: shedding underperforming holdings while bringing in new units with turnaround potential. For the Munich-based group, the pace of corporate transactions shows no sign of slowing.

Shares Edge Higher but Remain Down for the Year

Equity markets have yet to fully price in the operational overhaul. Mutares stock closed Friday at EUR 24.65, a modest daily gain of 1.9%, though it remains 18% lower since the start of the year.

Investors now look ahead to 12 November, when the company is due to publish third-quarter 2026 results — the next significant date on its financial calendar.